Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Goodwill (2016 - 2026)

Ekso Bionics Holdings has reported Goodwill over the past 10 years, most recently at $431000.0 for Q4 2025.

  • On a quarterly basis, Goodwill changed 0.0% to $431000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $431000.0, a 0.0% change, with the full-year FY2025 number at $431000.0, changed 0.0% from a year prior.
  • Goodwill reached $431000.0 in Q4 2025 per EKSO's latest filing, roughly flat from $431000.0 in the prior quarter.
  • The five-year high for Goodwill was $431000.0 in Q4 2022, with the low at $431000.0 in Q4 2022.
  • The 4-year median for Goodwill is $431000.0 (2022), against an average of $431000.0.
  • The largest YoY upside for Goodwill was 0.0% in 2023 against a maximum downside of 0.0% in 2023.
  • Tracing EKSO's Goodwill over 4 years: stood at $431000.0 in 2022, then changed by 0.0% to $431000.0 in 2023, then changed by 0.0% to $431000.0 in 2024, then changed by 0.0% to $431000.0 in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $431000.0, $431000.0, and $431000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.